- Article metrics
- Last updated: Fri, 4 Jul 2025 14:02:43 Z
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
Access & Citations
-
- 77k
- Article Accesses
-
- 108
- Citations
Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.
Online attention
- 1658 tweeters
- 4 blogs
- 5 Facebook pages
- 312 news outlets
- 3 Redditors
- 138 Mendeley
This article is in the 99th percentile (ranked 61st) of the 416,683 tracked articles of a similar age in all journals and the 98th percentile (ranked 3rd) of the 174 tracked articles of a similar age in Nature Medicine
View more on Altmetric
Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.
Mentions in news and blogs
-
Vaccine Shows Success in Preventing Cancer Relapse
Today Headline -
Cancer Vaccine Safe, Induces T-Cell Responses for KRAS-Mutated Tumors
Physician's Weekly -
MIT's Albumin-based cancer vaccine shows promising results in trials
Interesting Engineering
This list highlights individual mainstream news articles and blogs that cite the article. Not all news and blogs link to articles in a way that Altmetric can pick up, so they are not representative of all media. Altmetric are responsible for the curation of this list and provide updates hourly.